Gonorrhea Therapeutics Market
Gonorrhea Therapeutics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029
Analysis of Gonorrhea Therapeutics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT3761MR
- 04 Mar 2022
- Healthcare
- 170 Pages
- 52 Tables
- 202 Figures
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Globals Market Demand (in Value US$ Mn) Analysis 2014 to 2018 and Forecast, 2019 to 2029
- 6. Market Background
- 7. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Region
- 7.1. North America
- 7.2. Latin America
- 7.3. Europe
- 7.4. Middle East and Africa (MEA)
- 7.5. East Asia
- 7.6. South Asia
- 7.7. Oceania
- 8. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Drug Type
- 8.1. Macrolide Antibiotics (Azithromycin)
- 8.2. Third-Generation Cephalosporin
- 8.2.1. Cefixime
- 8.2.2. Cefotaxime
- 8.2.3. Ceftizoxime
- 8.2.4. Ceftriaxone
- 8.2.5. Cetriaxone
- 8.3. Tetracycline Antibiotics (Doxycycline)
- 8.4. Fluoroquinolones Antibiotics (Gemifloxacin)
- 8.5. Aminoglycoside (Gentamicin)
- 8.6. Aminocyclitol (Spectinomycin)
- 9. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Therapy Type
- 9.1. Mono Therapy
- 9.2. Dual Therapy
- 10. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Route of Administration
- 10.1. Oral
- 10.2. Intra Muscular
- 11. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Distribution Channel
- 11.1. Institutional Sales
- 11.1.1. Hospitals
- 11.1.2. Speciality Clinics
- 11.2. Retail Sales
- 11.2.1. Hospital Pharmacy
- 11.2.2. Retail Pharmacy
- 11.2.3. Mail Order Pharmacy
- 11.1. Institutional Sales
- 12. North Americas Market Analysis 2014 to 2018 and Forecast 2018 to 2029
- 13. Latin Americas Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 14. Europes Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 15. South Asias Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 16. East Asias Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 17. Oceanias Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 18. Middle East and Africas Market Analysis 2014 to 2018 and Forecast 2019 to 2029
- 19. Competition Analysis
- 19.1. Bayer AG
- 19.2. GlaxoSmithKline Plc.
- 19.3. Pfizer Inc.
- 19.4. Allergan plc
- 19.5. Novartis AG
- 19.6. Sanofi S.A.
- 19.7. Mylan N.V.
- 19.8. Teva Pharmaceutical Industries Ltd.
- 19.9. Baxter International Inc.
- 19.10. Hoffmann-La Roche Ltd.
- 19.11. Merck & Co.
- 20. Forecast Assumptions: Relevance and Impact
- 21. Assumptions and Acronyms Used
- 22. Research Methodology
List Of Table
Table 01: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Region
Table 02: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 2.1: Global Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 03: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy Type
Table 04: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 05: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 06: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 07: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 7.1: North America Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 08: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 09: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 10: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 11: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 12: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 12.1: Latin America Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 13: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 14: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 15: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 16: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 17: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 17.1: Europe Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 18: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 19: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 20: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 21: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 22: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 22.1: South Asia Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 23: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 24: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 25: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 26: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 27: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 27.1: East Asia Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 28: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 29: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 30: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 31: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 32: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 32.1: Oceania Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 33: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 34: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 35: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 36: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 37: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 37.1: Oceania Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 38: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 39: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 40: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 41: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 42: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 43: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 44: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 45: Japan Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 46: Japan Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 47: Japan Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 48: Japan Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 49: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 50: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 51: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 52: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
List Of Figures
Figure 01: Globals Market Value Share 2018A, By Drug Type
Figure 02: Globals Market Value Share 2018A, By Therapy
Figure 03: Globals Market Value Share 2018A, By Route of Administration
Figure 04: Globals Market Value Share 2018A, By Distribution Channel
Figure 05: Global Market Value Analysis and Forecast, 2017 to 2029 (US$ Mn)
Figure 06: Global Market Value Opportunity Assessment, 2019 to 2029
Figure 07: Global Revenue Share by Region, 2019E and 2029F
Figure 08: Global Market Attractiveness Analysis, By Region, 2019E
Figure 09: Global Revenue Share (in US$ Mn) by Drug Type, 2019E and 2029F
Figure 10: Global Market Attractiveness Analysis, By Drug Type, 2019E
Figure 11: Global Revenue Share by Therapy Type, 2019E and 2029F
Figure 12: Global Market Attractiveness Analysis, By Therapy Type, 2019E
Figure 13: Global Revenue Share by Route of Administration, 2019E and 2029F
Figure 14: Global Market Attractiveness Analysis, By Route of Administration, 2019E
Figure 15: Global Revenue Share by Distribution Channel, 2019E and 2029F
Figure 16: Global Market Attractiveness Analysis, By Distribution Channel, 2019E
Figure 17: North Americas Market Value Share 2019E, By Drug Type
Figure 18: North Americas Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 19: North Americas Market Value Share 2019E, By Therapy
Figure 20: North Americas Market Value Share 2019E, By Route of Administration
Figure 21: North Americas Market Value Share 2019E, By Distribution Channel
Figure 22: North Americas Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 23: North Americas Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 24: North America Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 25: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 26: North America Market Attractiveness Analysis, By Country
Figure 27: North America Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 28: North America Market Attractiveness Analysis, By Country
Figure 29: North America Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 30: North America Market Attractiveness Analysis, By Therapy
Figure 31: North America Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 32: North America Market Attractiveness Analysis, By Route of Administration
Figure 33: North America Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 34: North America Market Attractiveness Analysis, By Distribution Channel
Figure 35: North America Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 36: Latin Americas Market Value Share 2019E, By Drug Type
Figure 37: Latin Americas Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 38: Latin Americas Market Value Share 2019E, By Therapy
Figure 39: Latin Americas Market Value Share 2019E, By Route of Administration
Figure 40: Latin Americas Market Value Share 2019E, By Distribution Channel
Figure 41: Latin Americas Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 42: Latin Americas Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 43: Latin America Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 44: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 45: Latin America Market Attractiveness Analysis, By Country
Figure 46: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 47: Latin America Market Attractiveness Analysis, By Drug Type
Figure 48: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 49: Latin America Market Attractiveness Analysis, By Therapy
Figure 50: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 51: Latin America Market Attractiveness Analysis, By Route of Administration
Figure 52: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 53: Latin America Market Attractiveness Analysis, By Distribution Channel
Figure 54: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 55: Europes Market Value Share 2019E, By Drug Type
Figure 56: Europes Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 57: Europes Market Value Share 2019E, By Therapy
Figure 58: Europes Market Value Share 2019E, By Route of Administration
Figure 59: Europes Market Value Share 2019E, By Distribution Channel
Figure 60: Europes Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 61: Europes Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 62: Europe Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 63: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 64: Europe Market Attractiveness Analysis, By Country
Figure 65: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 66: Europe Market Attractiveness Analysis, By Drug Type
Figure 67: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 68: Europe Market Attractiveness Analysis, By Therapy
Figure 69: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 70: Europe Market Attractiveness Analysis, By Route of Administration
Figure 71: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 72: Europe Market Attractiveness Analysis, By Distribution Channel
Figure 73: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 74: South Asias Market Value Share 2019E, By Drug Type
Figure 75: South Asias Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 76: South Asias Market Value Share 2019E, By Therapy
Figure 77: South Asias Market Value Share 2019E, By Route of Administration
Figure 78: South Asias Market Value Share 2019E, By Distribution Channel
Figure 79: South Asias Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 80: South Asias Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 81: South Asia Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 82: South Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 83: South Asia Market Attractiveness Analysis, By Country
Figure 84: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 85: South Asia Market Attractiveness Analysis, By Drug Type
Figure 86: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 87: South Asia Market Attractiveness Analysis, By Therapy
Figure 88: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 89: South Asia Market Attractiveness Analysis, By Route of Administration
Figure 90: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 91: South Asia Market Attractiveness Analysis, By Distribution Channel
Figure 92: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 93: East Asias Market Value Share 2019E, By Drug Type
Figure 94: East Asias Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 95: East Asias Market Value Share 2019E, By Therapy
Figure 96: East Asias Market Value Share 2019E, By Route of Administration
Figure 97: East Asias Market Value Share 2019E, By Distribution Channel
Figure 98: East Asias Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 99: East Asias Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 100: East Asia Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 101: East Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 102: East Asia Market Attractiveness Analysis, By Country
Figure 103: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 104: East Asia Market Attractiveness Analysis, By Drug Type
Figure 105: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 106: East Asia Market Attractiveness Analysis, By Therapy
Figure 107: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 108: East Asia Market Attractiveness Analysis, By Route of Administration
Figure 109: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 110: East Asia Market Attractiveness Analysis, By Distribution Channel
Figure 111: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 112: Oceanias Market Value Share 2019E, By Drug Type
Figure 113: Oceanias Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 114: Oceanias Market Value Share 2019E, By Therapy
Figure 115: Oceanias Market Value Share 2019E, By Route of Administration
Figure 116: Oceanias Market Value Share 2019E, By Distribution Channel
Figure 117: Oceanias Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 118: Oceanias Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 119: Oceania Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 120: Oceania Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 121: Oceania Market Attractiveness Analysis, By Country
Figure 122: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 123: Oceania Market Attractiveness Analysis, By Drug Type
Figure 124: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 125: Oceania Market Attractiveness Analysis, By Therapy
Figure 126: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 127: Oceania Market Attractiveness Analysis, By Route of Administration
Figure 128: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 129: Oceania Market Attractiveness Analysis, By Distribution Channel
Figure 130: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 131: Middle East & Africas Market Value Share 2019E, By Drug Type
Figure 132: Middle East & Africas Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 133: Middle East & Africas Market Value Share 2019E, By Therapy
Figure 134: Middle East & Africas Market Value Share 2019E, By Route of Administration
Figure 135: Middle East & Africas Market Value Share 2019E, By Distribution Channel
Figure 136: Middle East & Africas Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 137: Middle East & Africas Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 138: Middle East & Africa Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 139: Middle East & Africa Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 140: Middle East & Africa Market Attractiveness Analysis, By Country
Figure 141: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 142: Middle East & Africa Market Attractiveness Analysis, By Drug Type
Figure 143: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 144: Middle East & Africa Market Attractiveness Analysis, By Therapy
Figure 145: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 146: Middle East & Africa Market Attractiveness Analysis, By Route of Administration
Figure 147: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 148: Middle East & Africa Market Attractiveness Analysis, By Distribution Channel
Figure 149: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 150: Emerging Countries Market Value Share (2019E)
Figure 151: Emerging Countries Market Value (US$ Mn), By Key Countries, 2014A to 2029E
Figure 152: Chinas Market Value Share 2019E, By Drug Type
Figure 153: Chinas Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 154: Chinas Market Value Share 2019E, By Therapy
Figure 155: Chinas Market Value Share 2019E, By Route of Administration
Figure 156: Chinas Market Value Share 2019E, By Distribution Channel
Figure 157: Chinas Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 158: Chinas Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 159: China Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 160: China Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 161: China Market Attractiveness Analysis, By Country
Figure 162: China Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 163: China Market Attractiveness Analysis, By Therapy
Figure 164: China Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 165: China Market Attractiveness Analysis, By Route of Administration
Figure 166: China Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 167: China Market Attractiveness Analysis, By Distribution Channel
Figure 168: China Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 169: Japans Market Value Share 2019E, By Drug Type
Figure 170: Japans Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 171: Japans Market Value Share 2019E, By Therapy
Figure 172: Japans Market Value Share 2019E, By Route of Administration
Figure 173: Japans Market Value Share 2019E, By Distribution Channel
Figure 174: Japans Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 175: Japans Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 176: Japan Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 177: Japan Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 178: Japan Market Attractiveness Analysis, By Country
Figure 179: Japan Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 180: Japan Market Attractiveness Analysis, By Therapy
Figure 181: Japan Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 182: Japan Market Attractiveness Analysis, By Route of Administration
Figure 183: Japan Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 184: Japan Market Attractiveness Analysis, By Distribution Channel
Figure 185: Japan Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 186: Indias Market Value Share 2019E, By Drug Type
Figure 187: Indias Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 188: Indias Market Value Share 2019E, By Therapy
Figure 189: Indias Market Value Share 2019E, By Route of Administration
Figure 190: Indias Market Value Share 2019E, By Distribution Channel
Figure 191: Indias Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 192: Indias Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 193: India Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 194: India Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 195: India Market Attractiveness Analysis, By Country
Figure 196: India Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 197: India Market Attractiveness Analysis, By Therapy
Figure 198: India Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 199: India Market Attractiveness Analysis, By Route of Administration
Figure 200: India Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 201: India Market Attractiveness Analysis, By Distribution Channel
Figure 202: India Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Gonorrhea Therapeutics Market